| layout | title | subtitle |
|---|---|---|
page |
Research |
Methods research and collaborative work |
[//]: For a list of my publications and pre-prints, please visit my Google Scholar profile page.
-
F. Bu, A. E. Aiello, A. Volfovsky, and J. Xu.
Likelihood-based Inference for Partially Observed Stochastic Epidemics with Individual Heterogeneity (2024). Biostatistics. -
F. Bu, J. Kagaayi, M. K. Grabowski, J. Xu, and O. Ratmann. Inferring HIV Transmission Patterns from Viral Deep-Sequence Data via Latent Spatial Poisson Processes (2024). Biometrics.
-
F. Bu, A. E. Aiello, J. Xu, and A. Volfovsky. Likelihood-based Inference for Partially Observed Epidemics on Dynamic Networks (2020). Journal of the American Statistical Association.
-
F. Bu, M. J. Schuemie, A. Nishimura, L. H. Smith, K. Kostka, T. Falconer, J. A. McLeggon, P. B. Ryan, G. Hripcsak, and M. A. Suchard. Bayesian Safety Surveillance with Adaptive Bias Correction (2023). Statistics in Medicine.
-
M. Schuemie, F. Bu, A. Nishimura and M. Suchard. Adjusting for Both Sequential Testing and Systematic Error in Safety Surveillance using Observational Data: Empirical Calibration and MaxSPRT (2023). Statistics in Medicine.
[//]: #### Social networks, sports analytics, and natural language processing
[//]: F. Bu, S. Xu, K. Heller, and A. Volfovsky. SMOGS: Social Network Metrics of Game Success (2019). The 22nd International Conference on Artificial Intelligence and Statistics (AISTATS).
[//]: W. Zhang, F. Bu, D. Owen-Oas, K. Heller, and X. Zhu. Who Started It? Identifying Root Sources in Textual Conversation Threads (2018). arXiv preprint.
- R. Khera, A. Aminorroaya, L. S. Dhingra, P. M. Thangaraj, A. P. Camargos, F. Bu, ..., and M. A. Suchard. Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study (2024). Journal of the American College of Cardiology.
- R. Khera, L.S. Dhingra, A. Aminorroaya, ..., F. Bu, ..., and M. A. Suchard. Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM (2023). BMJ medicine.
- F. Arshad, M. J. Schuemie, F. Bu, ..., and M. A. Suchard. Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance (2023). Drug Safety.
- E. A. Voss, A. Shoaibi, L. Y. H. Lai, ..., F. Bu, ..., and Patrick B Ryan. Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study (2023). EClinicalMedicine.
- R. Asencio, F. Bu, L. Tucker, G. Varela, J. Moody, and A. Volfovsky. Network Position and Emergent Phenomena: A Multi-team System Case Study (2022+). Under revisions.